Risk factor
Strong & resilient to price shocks
Profitability factor
Slightly undervalued vs peers
About
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o
Target Price
The average target price of DMP.DE is 44 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell